drugset / Trial / NCT05469750
Dalpiciclib Plus Letrozole and Capecitabine
NaSingle-groupOpen-labelTreatment
Summary
to assess the effect of dalpiciclib plus letrozole and capecitabine of first-line treatment with breast cancer
Timeline
- Start
- 2022-08-10
- Primary completion
- 2023-08
- Completion
- 2024-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Dalpiciclib | Small molecule | 150 mg | Oral |
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |